WallStreetZenWallStreetZen

NASDAQ: ORGO
Organogenesis Holdings Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Organogenesis Holdings earnings were $20.0M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest ORGO earnings report on Dec 31, 2025 announced Q4 2025 earnings of $35.1M, up 141.8% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ORGO reported annual earnings of $20.0M, with -2,236.8% growth. The next ORGO earnings date is May 7, 2026.

ORGO past earnings growth

How has ORGO's earnings growth performed historically?

Company
N/A
Industry
54.28%
Market
87.43%
ORGO's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
ORGO's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

ORGO earnings history

Current Revenue
$564.2M
Current Earnings
$20.0M
Current Profit Margin
3.5%

ORGO Return on Equity

Current Company
7.8%
Current Industry
13.6%
Current Market
28.8%
ORGO's Return on Equity (7.8%)... subscribe to Premium to read more.
High Return on Equity Performance

ORGO Return on Assets

Current Company
3.9%
Current Industry
5.4%
ORGO is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ORGO announces earnings.

ORGO Return on Capital Employed

Current Company
8.96%
Current Industry
11.7%
ORGO has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ORGO vs Pharmaceutical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ORGO$71.63M$20.02M0.00%$0.16
CGC-$207.31M-$236.65MN/A-$1.36
EOLS-$22.53M-$51.64MN/A-$0.80
SIGA$30.94M$23.28M-14.21%$0.33
EBS$237.90M$52.60M-29.93%$0.98
View Top Pharmaceutical Stocks

ORGO earnings dates

Next earnings date
May 7, 2026

Organogenesis Holdings Earnings Reports & History FAQ

What were Organogenesis Holdings's earnings last quarter?

On ORGO's earnings call on Invalid Date, Organogenesis Holdings (NASDAQ: ORGO) reported Q4 2025 earnings per share (EPS) of $0.28, up 600% year over year. Total ORGO earnings for the quarter were $35.12 million. In the same quarter last year, Organogenesis Holdings's earnings per share (EPS) was $0.04.

If you're new to stock investing, here's how to buy Organogenesis Holdings stock.

When does Organogenesis Holdings report earnings?

The next ORGO earnings call is Invalid Date. Add ORGO to your watchlist to be reminded of Organogenesis Holdings's next earnings date.

Is Organogenesis Holdings profitable or losing money?

As of the last Organogenesis Holdings earnings report, Organogenesis Holdings is currently profitable. Organogenesis Holdings's net profit (also called net income) for the twelve months ending Dec 31, 2025 was $37.03 million, a 4,201.05% increase year over year.

What was ORGO's earnings growth in the past year?

As of Organogenesis Holdings's earnings date in Invalid Date, Organogenesis Holdings's earnings has grown year over year. ORGO earnings in the past year totalled $20.02 million.

What are Organogenesis Holdings's earnings expectations?

The current EPS estimate for Organogenesis Holdings's earnings report in Invalid Date is -$0.08.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.